Pharminent

AbbVie Unveils 4 Global R&D Collaborations Focused on Advancing Next-Gen Science

With more than 50 compounds in clinical development, AbbVie’s pipeline spans significant areas of medical need including oncology, immunology, neuroscience and virology. http://www.dddmag.com/news/2017/01/abbvie-unveils-4-global-r-d-collaborations-focused-advancing-next-gen-science

Filed under: Company